Toxicology Drug Screening Market
Screen the Key Trends Influencing the Sales of Toxicology Drug Screening Kitss
Toxicology Drug Screening Market by Product Type, Test, Technology, End Use & Region - Forecast 2022 - 2032
Toxicology Drug Screening Market Outlook (2022-2032)
[323 Pages Report] The global toxicology drug screening market is anticipated to reach US 71,901.8 million by 2032, up from US$ $ 23,888.5 million in 2022 advancing at a rapid CAGR of 10.5% during the forecast period.
The demand for toxicology drug screening is on the surge as toxicology screening process can be done very quickly and provides approximate results showing the presence of specific drug in the system.
Toxicological screening is done for four primary purposes that includes medical testing, employment drug testing, forensic analysis, and athletics testing and the adoption of the same rises as it enables control in consumption of illegal drugs.
A doctor or physician performs a toxicology screen in case of accidents or sexual assaults on a person if suspected with the drug intoxication or overdose symptoms including unconsciousness, panic attacks, chest pain, deliriousness, and seizures. Furthermore, the toxicology drug screening market growth is fostered by its use before undergoing an organ transplant, drug abuse, during pregnancy.
|
Report Attribute |
Details |
|
Toxicology Drug Screening Market Value (2022) |
US$ 23,888.5 Million |
|
Toxicology Drug Screening Market Anticipated Forecast Value (2032) |
US 71,901.8 Million |
|
Toxicology Drug Screening Market Projected Growth Rate (2022-2032) |
10.5% |
Toxicology drug screening find vast applications in food and beverage industries, chemical industries, cosmetics and households and pharmaceutical companies which augments the adoption of toxicology drug screening.
These screening tests are majorly intended for detection of illegal drugs in victim’s blood or urine sample. Biochemical assays, cellular assays, reagents and kits, in silico services are the major type of toxicological drug screening products available in the industry.
Many of these screening tests are performed to determine systemic toxicity, carcinogenicity, dermal toxicity, genotoxicity, neurotoxicity, and organ-specific toxicity and thus contribute majorly to the revenue generation in toxicology drug screening market.
The toxicology drug screening market outlook is swayed by these toxicology drug screening methods as they are performed using various high-end technologies such as high-throughput screening, genomics, transcriptomics, and molecular screening.
The increasing usage of toxicological screening generates large revenues in the toxicology drug screening market owing to their growing demand in hospitals and trauma centers, rehabilitation centers and forensic laboratories.
Increasing adoption of in-vitro methods to detect toxic drugs in human system tends to propel the growth of toxicology drug screening market across the globe and registers a significant revenue growth in the toxicology drug screening market.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
What Factors are Spearheading the Toxicology Drug Screening Market?
Growing technological advancements leading to development of novel screening products are majorly contributing to the rising adoption of toxicology drug screening worldwide. Moreover, increasing availability of high-end drug screening instruments, reagent and kits coupled with wide application areas for toxicology drug screening are also expected to drive the growth of toxicology drug screening market.
Introduction of rapid and automated toxicity detection technologies, increasing government expenditure on toxicity testing and favorable reimbursement policies in toxicity screening is further fostering the toxicology drug screening market. Also, rise in demand for toxicology drug screening in the food and beverage industry, and chemical industry is also expected to drive the overall market growth.
However, inadequate efficacy of conventional techniques and longer time taken by laboratories for sample testing are some of the factors restraining the toxicology drug screening market during the forecast period.
What Factors Contribute to the North America’s Leading Position in the Toxicology Drug Screening Market?
On account of the expanding research and development activities in this area to detect toxicity levels in the human body at early stages, North America is likely to hold a market share of 42% in 2022. As these trials are being outsourced to other locations, such as Asia, research and development in this region has hit a plateau.
In addition, pharmaceutical companies' R&D expenses have increased in recent years, owing to the increasing burden of diseases, therapy sectors, and complex compounds, expanding the toxicology drug screening market size in the region.
Sabyasachi Ghosh
Principal Consultant
Talk to Analyst
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat are the Growth Prospects for the Europe Toxicology Drug Screening Market?
By 2022, Europe is anticipated to get hold of a toxicology drug screening market share of 31.0% primarily due to growing R&D activities to detect toxicity levels in the human body at early stages.
Regulatory approvals, new products, and product launches are projected to drive the growth of the Europe drug screening market during the forecast period.
Furthermore, rising government financing is expected to move the European toxicology drug screening market forward.
How is the Start-Up Ecosystem in the Toxicology Drug Screening Market?
A wide array of toxicology drug screening market opportunities are opened up by the emerging start-ups in the toxicology drug screening market.
Examples:
- Nagi Bioscience, a start-up based in Switzerland aims to revolutionise the way toxic and/or beneficial effects of substances are tested today by combining the use of microscopic worms as in vivo models for drug/chemical screening with the first technological platform for their fully automated in vitro culture, treatment, and multi-parametric analysis.
Increasing innovation and efficiency in the pharmaceutical, chemical, and cosmetic sectors, while also contributing to the replacement, refinement, and reduction of animal testing.
- Today, the pharmaceutical business relies on the in-vitro cell-based high-content-screening (HCS) market, which was valued at $557 million in 2017, but frequently overlooks minor traits. Humanized models are a better predictor of disease pathology, but no HCS assays are available.
Newormics' first product, a microfluidic-based technology, provides fast automated phenotyping of humanised C. elegans disease models and selects leads to address the unmet demand for HCS employing humanised animal models.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
What is the Competition Landscape in the Toxicology Drug Screening Market?
The toxicology drug screening market is consolidated and fairly competitive, with a few prominent competitors capturing major chunk of toxicology drug screening market share.
Some of the recent developments in the market are:
- Chief. AI, a machine learning operations platform, introduced the first no-code, pay-as-you-go artificial intelligence (AI) platform for drug development in collaboration with the Medicines Discovery Catapult.
- Mydecine Innovations Group, an emerging biopharma and life sciences company dedicated to development, acceptance of alternative nature-sourced medicine for mainstream use, and research has announced the launch of its in-silico drug discovery programme in collaboration with researchers at the University of Alberta.
Key Players
- Agilent Technologies, Inc.
- Covance, Inc.
- Bio-Rad Laboratories, Inc.
- General Electric Company
- BioReliance, Inc.
- Thermo Fisher Scientific, Inc.
- Eurofins Scientific SE
- GE Healthcare
- Quest Diagnostics
- Alere, Inc.
- Enzo Life Sciences, Inc.
Report Scope
|
Report Attribute |
Details |
|
Growth Rate |
CAGR of 10.5% from 2022 to 2032 |
|
Base Year for Estimation |
2021 |
|
Historical Data |
2016-2021 |
|
Forecast Period |
2022-2032 |
|
Quantitative Units |
Revenue in USD Million and CAGR from 2022-2032 |
|
Report Coverage |
Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
|
Segments Covered |
|
|
Regions Covered |
|
|
Key Countries Profiled |
|
|
Key Companies Profiled |
|
|
Customization |
Available Upon Request |
Key Segments Profiled in the Toxicology Drug Screening Market Survey
By Product Type:
- Monitoring and logging
- Security
- Storage and continuous integration/continuous deployment
- Management and orchestration
- Networking and data management services
- Others
By Test Type:
- Acute Systemic Toxicity
- Dermal Toxicity
- Carcinogenicity
- Ocular Toxicity
- Genotoxicity
- Neurotoxicity
- Organ-Specific Toxicity
By Technology Type:
- High-Throughput Screening
- Genomics
- Transcriptomics
- Toxicogenomics
- Molecular Screening
By End Use:
- Hospitals and Trauma Centers
- Forensic Laboratories
- Diagnostic Laboratories
- Rehabilitation Centers
- Pharmaceutical & Biotechnology Companies
By Region:
- North America
- Latin America
- Asia Pacific
- The Middle East and Africa
- Europe
Frequently Asked Questions
What are the Growth Prospects for the Toxicology Drug Screening Market?
The global toxicology drug screening market is likely to advance at a 10.5% CAGR (2022-2032).
Which Region Holds a Major Toxicology Drug Screening Market Share?
North America is projected to lead the toxicology drug screening market with a share of 42.0% in 2022.
What is the Future of the Toxicology Drug Screening Market?
Toxicology drug screening market is likely to garner a revenue of US 71,901.8 million by 2032.
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2017-2021 and Forecast, 2022-2032 4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Mn) Analysis By Product Type, 2017-2021 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product Type, 2022-2032 5.3.1. Assays 5.3.2. Biochemical Assays 5.3.3. Cellular Assays 5.3.4. Reagents & Kits 5.3.5. Enzyme Linked Immuno-Sorbent Assay (ELISA) 5.3.6. Polymerase Chain Reaction (PCR) 5.3.7. Enzyme Multiplied Immuno Assay (EMIT) 5.3.8. Radio Immuno-Sorbent Assay (RIA) 5.3.9. Instruments 5.3.10. Immunochemistry Analyzers 5.3.11. PCR machine 5.3.12. High-Performance Liquid Chromatography (HPLC) 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021 5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032 6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Test Type 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Mn) Analysis By Test Type, 2017-2021 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Test Type, 2022-2032 6.3.1. Acute Systemic Toxicity 6.3.2. Dermal Toxicity 6.3.3. Carcinogenicity 6.3.4. Ocular Toxicity 6.3.5. Genotoxicity 6.3.6. Neurotoxicity 6.3.7. Organ-Specific Toxicity 6.4. Y-o-Y Growth Trend Analysis By Test Type, 2017-2021 6.5. Absolute $ Opportunity Analysis By Test Type, 2022-2032 7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Technology Type 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Mn) Analysis By Technology Type, 2017-2021 7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Technology Type, 2022-2032 7.3.1. High-Throughput Screening 7.3.2. Genomics 7.3.3. Transcriptomics 7.3.4. Toxicogenomics 7.3.5. Molecular Screening 7.4. Y-o-Y Growth Trend Analysis By Technology Type, 2017-2021 7.5. Absolute $ Opportunity Analysis By Technology Type, 2022-2032 8. Global Market Analysis 2017-2021 and Forecast 2022-2032, By End User 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021 8.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032 8.3.1. Hospitals and Trauma Centers 8.3.2. Forensic Laboratories 8.3.3. Diagnostic Laboratories 8.3.4. Rehabilitation Centers 8.3.5. Pharmaceutical & Biotechnology Companies 8.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021 8.5. Absolute $ Opportunity Analysis By End User, 2022-2032 9. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region 9.1. Introduction 9.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021 9.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. Asia Pacific 9.3.5. MEA 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 10.2.1. By Country 10.2.1.1. U.S. 10.2.1.2. Canada 10.2.2. By Product Type 10.2.3. By Test Type 10.2.4. By Technology Type 10.2.5. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product Type 10.3.3. By Test Type 10.3.4. By Technology Type 10.3.5. By End User 10.4. Key Takeaways 11. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 11.2.1. By Country 11.2.1.1. Brazil 11.2.1.2. Mexico 11.2.1.3. Rest of Latin America 11.2.2. By Product Type 11.2.3. By Test Type 11.2.4. By Technology Type 11.2.5. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product Type 11.3.3. By Test Type 11.3.4. By Technology Type 11.3.5. By End User 11.4. Key Takeaways 12. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 12.2.1. By Country 12.2.1.1. Germany 12.2.1.2. U.K. 12.2.1.3. France 12.2.1.4. Spain 12.2.1.5. Italy 12.2.1.6. Rest of Europe 12.2.2. By Product Type 12.2.3. By Test Type 12.2.4. By Technology Type 12.2.5. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product Type 12.3.3. By Test Type 12.3.4. By Technology Type 12.3.5. By End User 12.4. Key Takeaways 13. Asia Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.1.4. India 13.2.1.5. Malaysia 13.2.1.6. Singapore 13.2.1.7. Australia 13.2.1.8. New Zealand 13.2.1.9. Rest of APAC 13.2.2. By Product Type 13.2.3. By Test Type 13.2.4. By Technology Type 13.2.5. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product Type 13.3.3. By Test Type 13.3.4. By Technology Type 13.3.5. By End User 13.4. Key Takeaways 14. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country 14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. South Africa 14.2.1.3. Israel 14.2.1.4. Rest of MEA 14.2.2. By Product Type 14.2.3. By Test Type 14.2.4. By Technology Type 14.2.5. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product Type 14.3.3. By Test Type 14.3.4. By Technology Type 14.3.5. By End User 14.4. Key Takeaways 15. Key Countries Market Analysis 15.1. U.S. 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2021 15.1.2.1. By Product Type 15.1.2.2. By Test Type 15.1.2.3. By Technology Type 15.1.2.4. By End User 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2021 15.2.2.1. By Product Type 15.2.2.2. By Test Type 15.2.2.3. By Technology Type 15.2.2.4. By End User 15.3. Brazil 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2021 15.3.2.1. By Product Type 15.3.2.2. By Test Type 15.3.2.3. By Technology Type 15.3.2.4. By End User 15.4. Mexico 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2021 15.4.2.1. By Product Type 15.4.2.2. By Test Type 15.4.2.3. By Technology Type 15.4.2.4. By End User 15.5. Germany 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2021 15.5.2.1. By Product Type 15.5.2.2. By Test Type 15.5.2.3. By Technology Type 15.5.2.4. By End User 15.6. U.K. 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2021 15.6.2.1. By Product Type 15.6.2.2. By Test Type 15.6.2.3. By Technology Type 15.6.2.4. By End User 15.7. France 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2021 15.7.2.1. By Product Type 15.7.2.2. By Test Type 15.7.2.3. By Technology Type 15.7.2.4. By End User 15.8. Spain 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2021 15.8.2.1. By Product Type 15.8.2.2. By Test Type 15.8.2.3. By Technology Type 15.8.2.4. By End User 15.9. Italy 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2021 15.9.2.1. By Product Type 15.9.2.2. By Test Type 15.9.2.3. By Technology Type 15.9.2.4. By End User 15.10. China 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2021 15.10.2.1. By Product Type 15.10.2.2. By Test Type 15.10.2.3. By Technology Type 15.10.2.4. By End User 15.11. Japan 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2021 15.11.2.1. By Product Type 15.11.2.2. By Test Type 15.11.2.3. By Technology Type 15.11.2.4. By End User 15.12. South Korea 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2021 15.12.2.1. By Product Type 15.12.2.2. By Test Type 15.12.2.3. By Technology Type 15.12.2.4. By End User 15.13. Malaysia 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2021 15.13.2.1. By Product Type 15.13.2.2. By Test Type 15.13.2.3. By Technology Type 15.13.2.4. By End User 15.14. Singapore 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2021 15.14.2.1. By Product Type 15.14.2.2. By Test Type 15.14.2.3. By Technology Type 15.14.2.4. By End User 15.15. Australia 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2021 15.15.2.1. By Product Type 15.15.2.2. By Test Type 15.15.2.3. By Technology Type 15.15.2.4. By End User 15.16. New Zealand 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2021 15.16.2.1. By Product Type 15.16.2.2. By Test Type 15.16.2.3. By Technology Type 15.16.2.4. By End User 15.17. GCC Countries 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2021 15.17.2.1. By Product Type 15.17.2.2. By Test Type 15.17.2.3. By Technology Type 15.17.2.4. By End User 15.18. South Africa 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2021 15.18.2.1. By Product Type 15.18.2.2. By Test Type 15.18.2.3. By Technology Type 15.18.2.4. By End User 15.19. Israel 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2021 15.19.2.1. By Product Type 15.19.2.2. By Test Type 15.19.2.3. By Technology Type 15.19.2.4. By End User 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Product Type 16.3.3. By Test Type 16.3.4. By Technology Type 16.3.5. By End User 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. Agilent Technologies, Inc. 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.2. Covance, Inc. 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.3. Bio-Rad Laboratories, Inc. 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.4. General Electric Company 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.5. BioReliance, Inc. 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.6. Thermo Fisher Scientific, Inc. 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.7. Eurofins Scientific SE 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.8. GE Healthcare 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.9. Quest Diagnostics 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.10. Alere, Inc. 17.1.10.1. Overview 17.1.10.2. Product Portfolio 17.1.10.3. Profitability by Market Segments 17.1.10.4. Sales Footprint 17.1.10.5. Strategy Overview 17.1.10.5.1. Marketing Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ Mn) Forecast by Region, 2017-2032 Table 2: Global Market Value (US$ Mn) Forecast by Product Type, 2017-2032 Table 3: Global Market Value (US$ Mn) Forecast by Test Type, 2017-2032 Table 4: Global Market Value (US$ Mn) Forecast by Technology Type, 2017-2032 Table 5: Global Market Value (US$ Mn) Forecast by End User, 2017-2032 Table 6: North America Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 7: North America Market Value (US$ Mn) Forecast by Product Type, 2017-2032 Table 8: North America Market Value (US$ Mn) Forecast by Test Type, 2017-2032 Table 9: North America Market Value (US$ Mn) Forecast by Technology Type, 2017-2032 Table 10: North America Market Value (US$ Mn) Forecast by End User, 2017-2032 Table 11: Latin America Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 12: Latin America Market Value (US$ Mn) Forecast by Product Type, 2017-2032 Table 13: Latin America Market Value (US$ Mn) Forecast by Test Type, 2017-2032 Table 14: Latin America Market Value (US$ Mn) Forecast by Technology Type, 2017-2032 Table 15: Latin America Market Value (US$ Mn) Forecast by End User, 2017-2032 Table 16: Europe Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 17: Europe Market Value (US$ Mn) Forecast by Product Type, 2017-2032 Table 18: Europe Market Value (US$ Mn) Forecast by Test Type, 2017-2032 Table 19: Europe Market Value (US$ Mn) Forecast by Technology Type, 2017-2032 Table 20: Europe Market Value (US$ Mn) Forecast by End User, 2017-2032 Table 21: Asia Pacific Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 22: Asia Pacific Market Value (US$ Mn) Forecast by Product Type, 2017-2032 Table 23: Asia Pacific Market Value (US$ Mn) Forecast by Test Type, 2017-2032 Table 24: Asia Pacific Market Value (US$ Mn) Forecast by Technology Type, 2017-2032 Table 25: Asia Pacific Market Value (US$ Mn) Forecast by End User, 2017-2032 Table 26: MEA Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 27: MEA Market Value (US$ Mn) Forecast by Product Type, 2017-2032 Table 28: MEA Market Value (US$ Mn) Forecast by Test Type, 2017-2032 Table 29: MEA Market Value (US$ Mn) Forecast by Technology Type, 2017-2032 Table 30: MEA Market Value (US$ Mn) Forecast by End User, 2017-2032
Sabyasachi Ghosh
Principal Consultant
Talk to Analyst
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Global Market Value (US$ Mn) by Product Type, 2022-2032 Figure 2: Global Market Value (US$ Mn) by Test Type, 2022-2032 Figure 3: Global Market Value (US$ Mn) by Technology Type, 2022-2032 Figure 4: Global Market Value (US$ Mn) by End User, 2022-2032 Figure 5: Global Market Value (US$ Mn) by Region, 2022-2032 Figure 6: Global Market Value (US$ Mn) Analysis by Region, 2017-2032 Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2022-2032 Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2022-2032 Figure 9: Global Market Value (US$ Mn) Analysis by Product Type, 2017-2032 Figure 10: Global Market Value Share (%) and BPS Analysis by Product Type, 2022-2032 Figure 11: Global Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032 Figure 12: Global Market Value (US$ Mn) Analysis by Test Type, 2017-2032 Figure 13: Global Market Value Share (%) and BPS Analysis by Test Type, 2022-2032 Figure 14: Global Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032 Figure 15: Global Market Value (US$ Mn) Analysis by Technology Type, 2017-2032 Figure 16: Global Market Value Share (%) and BPS Analysis by Technology Type, 2022-2032 Figure 17: Global Market Y-o-Y Growth (%) Projections by Technology Type, 2022-2032 Figure 18: Global Market Value (US$ Mn) Analysis by End User, 2017-2032 Figure 19: Global Market Value Share (%) and BPS Analysis by End User, 2022-2032 Figure 20: Global Market Y-o-Y Growth (%) Projections by End User, 2022-2032 Figure 21: Global Market Attractiveness by Product Type, 2022-2032 Figure 22: Global Market Attractiveness by Test Type, 2022-2032 Figure 23: Global Market Attractiveness by Technology Type, 2022-2032 Figure 24: Global Market Attractiveness by End User, 2022-2032 Figure 25: Global Market Attractiveness by Region, 2022-2032 Figure 26: North America Market Value (US$ Mn) by Product Type, 2022-2032 Figure 27: North America Market Value (US$ Mn) by Test Type, 2022-2032 Figure 28: North America Market Value (US$ Mn) by Technology Type, 2022-2032 Figure 29: North America Market Value (US$ Mn) by End User, 2022-2032 Figure 30: North America Market Value (US$ Mn) by Country, 2022-2032 Figure 31: North America Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 32: North America Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 33: North America Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 34: North America Market Value (US$ Mn) Analysis by Product Type, 2017-2032 Figure 35: North America Market Value Share (%) and BPS Analysis by Product Type, 2022-2032 Figure 36: North America Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032 Figure 37: North America Market Value (US$ Mn) Analysis by Test Type, 2017-2032 Figure 38: North America Market Value Share (%) and BPS Analysis by Test Type, 2022-2032 Figure 39: North America Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032 Figure 40: North America Market Value (US$ Mn) Analysis by Technology Type, 2017-2032 Figure 41: North America Market Value Share (%) and BPS Analysis by Technology Type, 2022-2032 Figure 42: North America Market Y-o-Y Growth (%) Projections by Technology Type, 2022-2032 Figure 43: North America Market Value (US$ Mn) Analysis by End User, 2017-2032 Figure 44: North America Market Value Share (%) and BPS Analysis by End User, 2022-2032 Figure 45: North America Market Y-o-Y Growth (%) Projections by End User, 2022-2032 Figure 46: North America Market Attractiveness by Product Type, 2022-2032 Figure 47: North America Market Attractiveness by Test Type, 2022-2032 Figure 48: North America Market Attractiveness by Technology Type, 2022-2032 Figure 49: North America Market Attractiveness by End User, 2022-2032 Figure 50: North America Market Attractiveness by Country, 2022-2032 Figure 51: Latin America Market Value (US$ Mn) by Product Type, 2022-2032 Figure 52: Latin America Market Value (US$ Mn) by Test Type, 2022-2032 Figure 53: Latin America Market Value (US$ Mn) by Technology Type, 2022-2032 Figure 54: Latin America Market Value (US$ Mn) by End User, 2022-2032 Figure 55: Latin America Market Value (US$ Mn) by Country, 2022-2032 Figure 56: Latin America Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 57: Latin America Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 58: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 59: Latin America Market Value (US$ Mn) Analysis by Product Type, 2017-2032 Figure 60: Latin America Market Value Share (%) and BPS Analysis by Product Type, 2022-2032 Figure 61: Latin America Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032 Figure 62: Latin America Market Value (US$ Mn) Analysis by Test Type, 2017-2032 Figure 63: Latin America Market Value Share (%) and BPS Analysis by Test Type, 2022-2032 Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032 Figure 65: Latin America Market Value (US$ Mn) Analysis by Technology Type, 2017-2032 Figure 66: Latin America Market Value Share (%) and BPS Analysis by Technology Type, 2022-2032 Figure 67: Latin America Market Y-o-Y Growth (%) Projections by Technology Type, 2022-2032 Figure 68: Latin America Market Value (US$ Mn) Analysis by End User, 2017-2032 Figure 69: Latin America Market Value Share (%) and BPS Analysis by End User, 2022-2032 Figure 70: Latin America Market Y-o-Y Growth (%) Projections by End User, 2022-2032 Figure 71: Latin America Market Attractiveness by Product Type, 2022-2032 Figure 72: Latin America Market Attractiveness by Test Type, 2022-2032 Figure 73: Latin America Market Attractiveness by Technology Type, 2022-2032 Figure 74: Latin America Market Attractiveness by End User, 2022-2032 Figure 75: Latin America Market Attractiveness by Country, 2022-2032 Figure 76: Europe Market Value (US$ Mn) by Product Type, 2022-2032 Figure 77: Europe Market Value (US$ Mn) by Test Type, 2022-2032 Figure 78: Europe Market Value (US$ Mn) by Technology Type, 2022-2032 Figure 79: Europe Market Value (US$ Mn) by End User, 2022-2032 Figure 80: Europe Market Value (US$ Mn) by Country, 2022-2032 Figure 81: Europe Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 82: Europe Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 83: Europe Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 84: Europe Market Value (US$ Mn) Analysis by Product Type, 2017-2032 Figure 85: Europe Market Value Share (%) and BPS Analysis by Product Type, 2022-2032 Figure 86: Europe Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032 Figure 87: Europe Market Value (US$ Mn) Analysis by Test Type, 2017-2032 Figure 88: Europe Market Value Share (%) and BPS Analysis by Test Type, 2022-2032 Figure 89: Europe Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032 Figure 90: Europe Market Value (US$ Mn) Analysis by Technology Type, 2017-2032 Figure 91: Europe Market Value Share (%) and BPS Analysis by Technology Type, 2022-2032 Figure 92: Europe Market Y-o-Y Growth (%) Projections by Technology Type, 2022-2032 Figure 93: Europe Market Value (US$ Mn) Analysis by End User, 2017-2032 Figure 94: Europe Market Value Share (%) and BPS Analysis by End User, 2022-2032 Figure 95: Europe Market Y-o-Y Growth (%) Projections by End User, 2022-2032 Figure 96: Europe Market Attractiveness by Product Type, 2022-2032 Figure 97: Europe Market Attractiveness by Test Type, 2022-2032 Figure 98: Europe Market Attractiveness by Technology Type, 2022-2032 Figure 99: Europe Market Attractiveness by End User, 2022-2032 Figure 100: Europe Market Attractiveness by Country, 2022-2032 Figure 101: Asia Pacific Market Value (US$ Mn) by Product Type, 2022-2032 Figure 102: Asia Pacific Market Value (US$ Mn) by Test Type, 2022-2032 Figure 103: Asia Pacific Market Value (US$ Mn) by Technology Type, 2022-2032 Figure 104: Asia Pacific Market Value (US$ Mn) by End User, 2022-2032 Figure 105: Asia Pacific Market Value (US$ Mn) by Country, 2022-2032 Figure 106: Asia Pacific Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 107: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 108: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 109: Asia Pacific Market Value (US$ Mn) Analysis by Product Type, 2017-2032 Figure 110: Asia Pacific Market Value Share (%) and BPS Analysis by Product Type, 2022-2032 Figure 111: Asia Pacific Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032 Figure 112: Asia Pacific Market Value (US$ Mn) Analysis by Test Type, 2017-2032 Figure 113: Asia Pacific Market Value Share (%) and BPS Analysis by Test Type, 2022-2032 Figure 114: Asia Pacific Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032 Figure 115: Asia Pacific Market Value (US$ Mn) Analysis by Technology Type, 2017-2032 Figure 116: Asia Pacific Market Value Share (%) and BPS Analysis by Technology Type, 2022-2032 Figure 117: Asia Pacific Market Y-o-Y Growth (%) Projections by Technology Type, 2022-2032 Figure 118: Asia Pacific Market Value (US$ Mn) Analysis by End User, 2017-2032 Figure 119: Asia Pacific Market Value Share (%) and BPS Analysis by End User, 2022-2032 Figure 120: Asia Pacific Market Y-o-Y Growth (%) Projections by End User, 2022-2032 Figure 121: Asia Pacific Market Attractiveness by Product Type, 2022-2032 Figure 122: Asia Pacific Market Attractiveness by Test Type, 2022-2032 Figure 123: Asia Pacific Market Attractiveness by Technology Type, 2022-2032 Figure 124: Asia Pacific Market Attractiveness by End User, 2022-2032 Figure 125: Asia Pacific Market Attractiveness by Country, 2022-2032 Figure 126: MEA Market Value (US$ Mn) by Product Type, 2022-2032 Figure 127: MEA Market Value (US$ Mn) by Test Type, 2022-2032 Figure 128: MEA Market Value (US$ Mn) by Technology Type, 2022-2032 Figure 129: MEA Market Value (US$ Mn) by End User, 2022-2032 Figure 130: MEA Market Value (US$ Mn) by Country, 2022-2032 Figure 131: MEA Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 132: MEA Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 133: MEA Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 134: MEA Market Value (US$ Mn) Analysis by Product Type, 2017-2032 Figure 135: MEA Market Value Share (%) and BPS Analysis by Product Type, 2022-2032 Figure 136: MEA Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032 Figure 137: MEA Market Value (US$ Mn) Analysis by Test Type, 2017-2032 Figure 138: MEA Market Value Share (%) and BPS Analysis by Test Type, 2022-2032 Figure 139: MEA Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032 Figure 140: MEA Market Value (US$ Mn) Analysis by Technology Type, 2017-2032 Figure 141: MEA Market Value Share (%) and BPS Analysis by Technology Type, 2022-2032 Figure 142: MEA Market Y-o-Y Growth (%) Projections by Technology Type, 2022-2032 Figure 143: MEA Market Value (US$ Mn) Analysis by End User, 2017-2032 Figure 144: MEA Market Value Share (%) and BPS Analysis by End User, 2022-2032 Figure 145: MEA Market Y-o-Y Growth (%) Projections by End User, 2022-2032 Figure 146: MEA Market Attractiveness by Product Type, 2022-2032 Figure 147: MEA Market Attractiveness by Test Type, 2022-2032 Figure 148: MEA Market Attractiveness by Technology Type, 2022-2032 Figure 149: MEA Market Attractiveness by End User, 2022-2032 Figure 150: MEA Market Attractiveness by Country, 2022-2032
Recommendations
Explore Healthcare Insights
View Reports
